1800-272-662
Shopping Cart 0
countryflagAU
Login

Encompass Health Corp

Healthcare US EHC

106.89USD
-1.73(1.59%)

Last update at 2026-03-10T20:00:00Z

Day Range

106.49109.56
LowHigh

52 Week Range

50.7871.90
LowHigh

Fundamentals

  • Previous Close 108.62
  • Market Cap6688.08M
  • Volume1196336
  • P/E Ratio18.79
  • Dividend Yield0.90%
  • EBITDA988.70M
  • Revenue TTM4691.70M
  • Revenue Per Share TTM47.19
  • Gross Profit TTM 1753.20M
  • Diluted EPS TTM3.55

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 450.80M 657.20M 472.60M 562.30M 493.20M
Minority interest -94.90000M -105.00000M -84.60000M -87.10000M -83.10000M
Net income 271.00M 412.20M 284.20M 358.70M 292.30M
Selling general administrative 2602.30M 3164.00M 2918.70M 2902.30M 2652.20M
Selling and marketing expenses - - - - -
Gross profit 4146.50M 4912.30M 4443.90M 4437.10M 4118.60M
Reconciled depreciation 243.60M 256.60M 243.00M 218.70M 199.70M
Ebit 627.90M 822.80M 661.90M 729.70M 692.50M
Ebitda 871.50M 1079.40M 904.90M 948.40M 892.20M
Depreciation and amortization 243.60M 256.60M 243.00M 218.70M 199.70M
Non operating income net other - 15.30M 11.80M -7.70000M 2.20M
Operating income 627.90M 822.80M 661.90M 729.70M 681.60M
Other operating expenses 3718.40M 4315.10M 3996.60M 3912.50M 3595.70M
Interest expense 175.70M 164.60M 184.20M 159.70M 147.30M
Tax provision 100.10M 139.60M 103.80M 115.90M 118.90M
Interest income 172.80M 160.60M 180.70M 153.00M 138.60M
Net interest income -175.70000M -164.60000M -184.20000M -159.70000M -147.30000M
Extraordinary items 13.90M -0.40000M 89.30M -0.60000M 1.10M
Non recurring - - 2.80M - -52.00000M
Other items - - - - -
Income tax expense 100.10M 139.60M 103.80M 115.90M 118.90M
Total revenue 4348.60M 5121.60M 4644.40M 4605.00M 4277.30M
Total operating expenses 3516.30M 4105.80M 3796.10M 3744.60M 3437.00M
Cost of revenue 202.10M 209.30M 200.50M 167.90M 158.70M
Total other income expense net -177.10000M -165.60000M -189.30000M -167.40000M -41.10000M
Discontinued operations 15.20M -0.40000M -0.40000M -0.60000M 1.10M
Net income from continuing ops 350.70M 517.60M 368.80M 446.40M 374.30M
Net income applicable to common shares 269.80M 412.20M 284.20M 358.70M 292.30M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 5636.50M 6864.90M 6445.90M 6080.70M 5227.40M
Intangible assets 282.30M 417.50M 431.30M 476.30M 443.40M
Earning assets - - - - -
Other current assets 127.00M 121.20M 86.40M 97.50M 66.20M
Total liab 3774.60M 4465.70M 4444.30M 4148.00M 3356.30M
Total stockholder equity 1310.30M 1911.30M 1588.00M 1352.20M 1329.10M
Deferred long term liab - 86.70M 51.80M - -
Other current liab 309.20M 219.70M 218.30M 303.80M 333.90M
Common stock 1.10M 1.10M 1.10M 1.10M 1.10M
Capital stock 1.10M 1.10M 1.10M 1.10M 1.10M
Retained earnings 115.70M 141.80M -242.30000M -526.50000M -885.20000M
Other liab 257.20M 259.90M 266.80M 159.90M 205.20M
Good will 1263.20M 2427.90M 2318.70M 2305.20M 2100.80M
Other assets 222.10M 254.50M 542.00M 300.20M 321.70M
Cash 21.80M 54.80M 224.00M 94.80M 69.20M
Cash and equivalents 21.80M 54.80M 224.00M 94.80M 69.20M
Total current liabilities 575.90M 748.80M 717.30M 721.00M 672.50M
Current deferred revenue 83.00M 310.30M 300.90M 242.90M 212.80M
Net debt 2970.50M 3483.40M 3319.30M 3252.00M 2445.20M
Short term debt 50.80M 81.20M 83.10M 79.70M 35.80M
Short long term debt 25.20M 42.80M 38.30M 39.30M 35.80M
Short long term debt total 2992.30M 3538.20M 3543.30M 3346.80M 2514.40M
Other stockholder equity 1193.50M 1768.40M 1829.20M 1877.60M 2213.20M
Property plant equipment 3151.70M 2843.60M 2452.30M 1959.30M 1634.80M
Total current assets 717.20M 921.40M 948.60M 755.80M 662.10M
Long term investments - - - 7.40M 12.20M
Net tangible assets -235.20000M -934.10000M -699.10000M -1189.70000M -1005.80000M
Short term investments - - - - -
Net receivables 536.80M 680.30M 572.80M 506.10M 467.70M
Long term debt 2741.80M 3243.90M 3250.60M 3023.30M 2478.60M
Inventory 31.60M 65.10M 65.40M 57.40M 59.00M
Accounts payable 132.90M 137.60M 115.00M 94.60M 90.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - 445.70M 382.00M 340.90M 280.30M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - -1211.80000M -1147.00000M
Additional paid in capital - - - - -
Common stock total equity - 1.10M 1.10M 1.10M 1.10M
Preferred stock total equity - - - - -
Retained earnings total equity - 141.80M -242.30000M -526.50000M -885.20000M
Treasury stock - -521.20000M -497.40000M -492.30000M -427.90000M
Accumulated amortization - - - - -
Non currrent assets other 139.10M 254.50M 295.00M 304.70M 291.00M
Deferred long term asset charges - - - - -
Non current assets total 4919.30M 5943.50M 5497.30M 5324.90M 4565.30M
Capital lease obligations 225.30M 251.50M 254.40M 284.20M -
Long term debt total 2741.80M 3243.90M 3250.60M 3023.30M 2478.60M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -627.00000M -666.30000M -407.50000M -657.40000M 65.10M
Change to liabilities 2.30M 14.90M 13.60M -6.10000M 6.60M
Total cashflows from investing activities -627.00000M -666.30000M -407.50000M -657.40000M -424.50000M
Net borrowings -498.20000M -66.30000M 208.90M 454.50M 20.60M
Total cash from financing activities -145.70000M -240.10000M -145.90000M 48.20M -321.20000M
Change to operating activities -15.80000M -68.60000M 17.20M -151.10000M 32.40M
Net income 365.90M 517.60M 368.80M 446.40M 374.30M
Change in cash -66.90000M -190.60000M 151.30M 26.10M 16.70M
Begin period cash flow 120.30M 310.90M 159.60M 133.50M 116.80M
End period cash flow 53.40M 120.30M 310.90M 159.60M 133.50M
Total cash from operating activities 705.80M 715.80M 704.70M 635.30M 762.40M
Issuance of capital stock - - - - -
Depreciation 243.60M 256.60M 243.00M 218.70M 199.70M
Other cashflows from investing activities -42.90000M 3.50M -11.50000M 231.50M 143.90M
Dividends paid 99.00M 112.40M 111.90M 108.70M 100.80M
Change to inventory - - - - -2.40000M
Change to account receivables -16.90000M -64.30000M -38.10000M -22.90000M 7.00M
Sale purchase of stock 0.00000M -6.10000M -6.10000M -45.90000M -65.60000M
Other cashflows from financing activities 703.30M 203.60M -234.60000M -273.20000M -130.10000M
Change to netincome 211.90M 157.20M 335.90M 189.50M 387.00M
Capital expenditures 584.10M 551.20M 408.20M 404.10M 270.50M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - -190.60000M 151.30M 26.10M 16.70M
Change in working capital -30.40000M -118.00000M -7.30000M -180.10000M 46.00M
Stock based compensation 29.20M 32.80M 29.50M 114.40M 85.90M
Other non cash items 69.60M -1.00000M 18.30M -4.10000M 65.60M
Free cash flow 121.70M 164.60M 296.50M 231.20M 491.90M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EHC
Encompass Health Corp		 -1.73 1.59% 106.89 18.79 17.64 1.43 4.29 2.03 9.45
HCA
HCA Holdings Inc		 -7.49 1.37% 537.64 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR		 0.05 0.36% 14.02 16.87 9.44 0.42 0.78 0.79 5.37
FSNUF
Fresenius SE & Co. KGaA		 - -% 54.35 16.76 9.62 0.42 0.79 0.78 5.31
JDHIY
JD Health International Inc		 - -% 9.08 62.50 35.97 0.30 2.32 0.16 3.90

Reports Covered

Stock Research & News

View All

Profile

Encompass Health Corporation provides post-acute healthcare services in the United States. It provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides services under the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.

Encompass Health Corp

9001 Liberty Parkway, Birmingham, AL, United States, 35242

Key Executives

Name Title Year Born
Mr. Mark J. Tarr CEO, Pres & Director 1962
Mr. Douglas E. Coltharp Exec. VP & CFO 1962
Mr. John Patrick Darby Exec. VP, Gen. Counsel & Corp. Sec. 1965
Ms. Elissa Joy Charbonneau Chief Medical Officer 1960
Mr. Andrew L. Price Sr. VP & Chief Accounting Officer 1967
Mr. Rusty Yeager Chief Information Officer & Sr. VP NA
Mr. Mark Miller Sr. VP of Investor Relations & Strategic Planning NA
Ms. Dawn Rock Chief Compliance Officer NA
Mr. Anthony A. Hernandez Chief HR Officer 1966
Mr. Frank Brown Pres of Southwest Region NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.